Relmada Therapeutics Announces Completion of Dosing with REL-1017 in Phase 2 Study of Individuals with Treatment Resistant Depression
REL-1017 is a novel NMDA receptor antagonist in development as a rapidly acting oral agent for the treatment of depression
News
HHS, DoD, VenatoRx Pharmaceuticals to Co-Develop Novel Antibiotic to Treat Drug-Resistant Infections
South Shore Health Selects Bainbridge Health to Enhance Medication Safety and Stewardship
Bainbridge Health is partnering with South Shore Health, a leading provider of emergency, acute and outpatient care, to enhance its efforts to improve safety and reduce medication waste.
Immunome Appoints Purnanand Sarma, PhD, as President and Chief Executive Officer
Industry Veteran to Take the Helm of Next-Generation Oncology Company Focused on Harnessing Human Immune Response
QR Pharma Adopts new Corporate Name: Annovis Bio
Change reflects enhanced focus on neurodegenerative diseases
Nemours Children’s Health System Expands Partnership with Bainbridge Health to Support Its Continued Commitment to Medication Safety
Bainbridge Health is partnering with Nemours Children’s Hospital to further support the system’s efforts to improve medication and infusion pump safety.
VenatoRx Pharmaceuticals Founders Named Entrepreneur Of The Year 2019 Award Winners in Greater Philadelphia
Group K Diagnostics Expands Research Team, Updates Lab and Manufacturing Facilities
Enhancements will triple manufacturing output capacity, improve production speed six-fold
Pillo Health Raises $11M in Series-A Funding from Stanley Black & Decker and Samsung Ventures to Fuel Development of Voice-First Healthcare Platform for the Home